Burtness B, Rischin D, Greil R, Soulieres D, et al. Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. J Clin Oncol 2022 Mar 25:JCO2102198. doi: 10.1200/JCO.21.02198.
PMID: 35333599